Posted on:
Jun 25, 2021 10:28PM
traveltext
wrote:
Gender screening discrimination
My mother developed breast cancer, aged 38, and died two years later. In my case, after contracting breast cancer, and two years later prostate cancer, my genetic test showed a BRCA1 mutation with a variation of unknown significance. My daughter, aged 48, was enrolled in a public screening program, which includes an annual MRI scan. However, my son, a few years younger, has no access to a public screening program and is on his own as far as check-ups go. This gender discrimination needs redressing.
READ MORE IN MY ARTICLE HERE
https://advancedbreastcancer.net/living/screening-...
NED breast and prostate cancer.
Dx 03/14, IBC, Lgth. 2cm, Stge IIIB, Gde 2B, ER+/PR+, HER2- ; FEC x3, Taxol x3; Mx & 2/23 nodes; Rads x 33; now on tamoxofin.
Chemotherapy
3/6/2014 Other
Chemotherapy
3/6/2014 AC + T (Taxotere)
Chemotherapy
3/10/2014 FAC
Hormonal Therapy
4/16/2014
Surgery
7/1/2014 Lymph node removal (Left); Mastectomy (Left)
Surgery
7/23/2014 Lymph node removal (Left); Mastectomy (Left)
Radiation Therapy
8/8/2014 Whole breast: Left breast, Lymph nodes
Radiation Therapy
8/22/2014 Whole breast: Left breast, Chest wall, Lymph nodes
Hormonal Therapy
10/24/2014 Liquid tamoxifen (Soltamox)
Hormonal Therapy
10/30/2014
Hormonal Therapy
11/1/2014
Surgery
5/8/2022
Radiation Therapy
Surgery
Surgery
Surgery
Hormonal Therapy
Surgery
Hormonal Therapy
Surgery
Surgery
Surgery
Surgery
Log in to post a reply
